Cargando…

Design considerations for early-phase clinical trials of immune-oncology agents

BACKGROUND: With numerous and fast approvals of different agents including immune checkpoint inhibitors, monoclonal antibodies, or chimeric antigen receptor (CAR) T-cell therapy, immunotherapy is now an established form of cancer treatment. These agents have demonstrated impressive clinical activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wages, Nolan A., Chiuzan, Cody, Panageas, Katherine S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Clinical Trials Monitor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103998/ https://www.ncbi.nlm.nih.gov/pubmed/30134959 http://dx.doi.org/10.1186/s40425-018-0389-8

Ejemplares similares

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
por: Jiang, Haiping, et al.
Publicado: (2022)

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
por: Zamarin, Dmitriy, et al.
Publicado: (2020)

Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
por: Redman, Jason M., et al.
Publicado: (2018)

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
por: Page, David B., et al.
Publicado: (2016)

Current clinical trials testing the combination of immunotherapy with radiotherapy
por: Kang, Josephine, et al.
Publicado: (2016)

‘You give me fever!’: are health services ready for immune cell engager therapy in advanced solid malignancies?
por: Pettinger, Claire, et al.
Publicado: (2022)

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
por: Anders, Carey K, et al.
Publicado: (2022)

PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
por: Grigg, Claud, et al.
Publicado: (2016)

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
por: Rehman, Hasan, et al.
Publicado: (2016)

Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
por: DeNardo, David G, et al.
Publicado: (2021)

Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification
por: De, Sourabh
Publicado: (2011)

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
por: Hobbs, Brian P, et al.
Publicado: (2018)

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study
por: Sack, Stefan, et al.
Publicado: (2011)

A day in the life of a monitor!
por: Shah, Kunal
Publicado: (2012)

Biocrust morphogroups provide an effective and rapid assessment tool for drylands
por: Read, Cassia F., et al.
Publicado: (2014)

FORUM: Ecological networks: the missing links in biomonitoring science
por: Gray, Clare, et al.
Publicado: (2014)

Tree‐centric mapping of forest carbon density from airborne laser scanning and hyperspectral data
por: Dalponte, Michele, et al.
Publicado: (2016)

Analysis of integrated clinical trial protocols in early phases of medicinal product development
por: Fruhner, Kevin, et al.
Publicado: (2017)

A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019)

The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
por: Dalla Bella, Eleonora, et al.
Publicado: (2021)

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial
por: Ferry, David, et al.
Publicado: (2017)

2203: Engraftment and gene expression of an HIV resistant immune system in a Phase I trial of an HIV stem cell gene therapy strategy
por: Anderson, Joseph, et al.
Publicado: (2018)

Single‐Agent Versus Double‐Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial
por: Zhao, Zhenhuan, et al.
Publicado: (2020)

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates
por: Ott, Patrick A., et al.
Publicado: (2010)

Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics
por: Townsend, Robert W., et al.
Publicado: (2017)

Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study
por: Pasquali, Theodore A., et al.
Publicado: (2022)

A web tool for designing and conducting phase I trials using the continual reassessment method
por: Wages, Nolan A., et al.
Publicado: (2018)

Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2017)

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial
por: Stebbing, Justin, et al.
Publicado: (2021)

Challenges, opportunities, and innovative statistical designs for precision oncology trials
por: Yin, Jun, et al.
Publicado: (2022)

Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study
por: Florian, Hana, et al.
Publicado: (2023)

Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma
por: Portell, Craig A., et al.
Publicado: (2022)

Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial
por: Gal, Roxanne, et al.
Publicado: (2021)

Sphincter preservation in patients with low rectal cancer: striking the right oncological balance
por: Luvisetto, Federico, et al.
Publicado: (2021)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer
por: Haddad, Tufia C., et al.
Publicado: (2017)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
por: Mease, Philip J., et al.
Publicado: (2020)

Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial
por: Hong, Ji Man, et al.
Publicado: (2022)

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009)

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial
por: Nomura, Takashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lhbmomm5odp9chvu2091g167gr